Embryo-fetal safety evaluation of ondansetron in rats.

Ana Carolina Casali ReisBárbara Campos JorgeSuyane da Silva MoreiraJúlia SteinCarolina Barizan PerdãoBeatriz de Matos ManoelArielle Cristina Arena

Published in: Birth defects research (2023)

In conclusion, therapeutic doses of ondansetron have low teratogenic potential in rats. These data provide important information about the drug safety during pregnancy.

Keyphrases

electronic health record
big data
healthcare
machine learning
risk assessment
social media
human health
climate change
adverse drug
pregnancy outcomes